Mounjaro tends to win the Mounjaro vs Ozempic decision for patients who: Have obesity (BMI 30) or are overweight with metabolic risk factors, and weight loss is the primary goal Have an HbA1c that hasnt responded well to metformin or older GLP-1 drugs Dont have a strong personal or family history of cardiovascular disease that specifically needs Ozempics proven protective data Can sustain the higher monthly cost for the 12+ months typically needed for lasting results Who Should Consider Ozempic (or Generic Semaglutide)
New or worsening abdominal pain, especially if its intense or localized, is another reason to contact your provider
This case is notable because the patient had previously tolerated dulaglutide without any injection site reactions, emphasizing that tolerance to one GLP-1 agonist does not predict tolerance to another
While focusing on nutrient-dense foods can make a difference, gaps can still exist
However, tirzepatide does not directly target liver fat oxidation the way survodutide does
People using inositol primarily for mental health support Inositol has been studied in psychiatric contexts (like OCD and panic disorder), but trials often use very high doses (e.g., 1218g/day), and results are mixed